Ask AI
ProCE Banner Activity

Pharmacists’ FAQs on the Novel Approaches in the Management of Acute and Chronic GVHD

Clinical Thought
Read this commentary from Eno-Abasi Inyang, PharmD, BCPS, BCOP, and Marissa Olson, PharmD, BCOP, on frequently asked questions regarding pharmacists’ use of novel approaches in the management of acute and chronic GVHD.

Released: February 01, 2022

Expiration: January 31, 2023

Continue Activity View Activity

Share

Provided by

Provided by ProCE, LLC
ProCE Banner

Supporters

This activity is supported by an educational grant from

Incyte Corporation

Faculty Disclosure

Primary Author

Eno-Abasi Inyang, PharmD, BCOP, BCPS

Stem Cell Transplant Clinical Pharmacy Specialist
Pharmacy Department
Dana Farber Cancer Institute
Boston, Massachusetts

Eno-Abasi Inyang, PharmD, BCOP, BCPS, has no conflicts of interest to report.

Marissa Olson, PharmD, BCOP

Clinical Pharmacy Specialist Hematologic Malignancies/Bone Marrow Transplant
Pharmacy
Barnes-Jewish Hospital
Saint Louis, Missouri

Marissa Olson, PharmD, BCOP, has no conflicts of interest to report.